Alternate TextTo enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
Home > Inhibitors & Agonists > Others

Others

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DC9643 Bevirimat(PA-457) Featured
Bevirimat(YK FH312; FH11327; MPC-4326) is an anti-HIV drug derived from a betulinic acid-like compound; is believed to inhibit HIV by a novel mechanism, so-called maturation inhibition.
More description
DC8786 NVP-BEZ235 Tosylate Featured
BEZ235 (NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor of p110α, p110γ, p110δ and p110β with IC50 of 4 nM, 5 nM, 7 nM and 75 nM, respectively, and also inhibits ATR with IC50 of 21 nM.
More description
DC23310 BI-3812 Featured
BI-3812 is potent and efficacious BCL6 inhibitor, inhibiting the BTB domain of BCL6, with an IC50 of ≤3 nM; BI-3812 has antitumor activity.
More description
DC22310 BI-4464 Featured
BI-4464 (BI 4464) is a potent, highly selective, ATP competitive inhibitor of Focal adhesion tyrosine kinase (PTK2/FAK) with IC50 of 17 nM..
More description
DC22281 Bilobalide Featured
Bilobalide is a sesquiterpene lactone which is found in extracts of G. biloba.
More description
DC8368 BIO-acetoxime Featured
BIO-Acetoxime is an analog of the GSK3 inhibitor 6-bromoindirubin-3’-oxime, or BIO
More description
DC10504 BISF-3 Featured
BISF CAS 118511-97-0
More description
DC8270 BML-277 Featured
BML-277 (C 3742) is a selective Chk2 (checkpoint kinase 2) inhibitor with an IC50 of 15 nM.
More description
DC32283 Azeliragon HCl Featured
Azeliragon 2HCl (also known as TTP488 2HCl and PF-04494700 2HCl) is a potent and orally bioactive RAGE (Receptor for Advanced Glycation End products) inhibitor that has the potential for the treatment of mild-to-moderate Alzheimer's disease and cerebral amyloid angiopathy. RAGE is a pattern recognition receptor that affects the movement of amyloid (a biomarker for Alzheimer's disease) into the brain. In preclinical studies, azeliragon decreased brain amyloid in mice and improved their performance on behavior tests. Azeliragon has been shown to be involved in adaptive immune responses. It is currently in Phase 3 clinical trial.
More description
DC22521 SAR405 Featured
SAR405 is a highly potent and selective PI3K class III isoform Vps34 inhibitor with IC50 of 1.2 nM, inhibits the formation of autophagosomes in GFP-LC3 cells with IC50 of 4 nM.
More description
DC12670 BMS-817378 free base Featured
BMS-817378 is a prodrug of the dual Met/VEGFR-2 inhibitor BMS-794833.
More description
DC7090 BMS-863233 (XL-413) Featured
BMS-863233, also known as XL-413, is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity.
More description
DC22037 Bobcat339 Featured
Bobcat339 (Bobcat 339) is a novel cytosine-based TET enzyme inhibitor with IC50 of 33 uM (TET1) and 73 uM (TET2), but not DNMT3a, does not inhibit the DNA methyltransferase DNMT3a.
More description
DC8294 BPR1J-097 Featured
BPR1J-097 is a novel small molecule FLT-3 inhibitor(IC50=11±7 nM) with promising in vivo anti-tumour activities; inhibits FLT-3 D835Y with an IC50 of 3 nM.
More description
DC10515 BQCA Featured
BQCA is a potent muscarinic M1 receptor positive allosteric modulator with selectivity for M1 over M2-M5.
More description
DC8202 BQU57 Featured
BQU57 is a potent and selective GTPase Ral Inhibitor.
More description
DC12375 Bragsin2 Featured
Bragsin2 is a novel PH-domain-binding inhibitor,inhibiting BRAG2-mediated Arf GTPase activation.
More description
DC23100 Brassinolide Featured
Brassinolide is a predominant plant growth modulator that regulate plant cell elongation. It is active against herpes and arena viruses.
More description
DC8386 Bromodeoxyuridine (BrdU) Featured
Bromodeoxyuridine (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells.
More description
DC10460 BT-11 Featured
BT-11 is an orally active and selective LANCL2 modulator.
More description
DC10164 BTB-1 Featured
BTB-1 is a small molecule inhibitor of the mitotic motor protein Kif18A.
More description
DC12044 CA-5f Featured
CA-5f is a novel late-stage autophagy inhibitor with potent anti-tumor effect against non-small cell lung cancer.
More description
DC10736 CaCC(inh)-A01 Featured
CaCC(inh)-A01 is a non-selective inhibitor of calcium-activated chloride channels (CaCCs) that blocks ATP-stimulated chloride conductance in human salivary gland, intestinal, and bronchial epithelium (mean IC50 = 10 µM).
More description
DC10457 Cadazolid (ACT-179811) Featured
Cadazolid (ACT-179811) is a novel fluoroquinolone-oxazolidinone antibiotic and a protein synthesis inhibitor.
More description
DC10327 Calcitonin salmon Featured
Calcitonin, Salmon is a calcium regulating hormone secreted from mammalian thyroid parafollicular cells and in non-mammalian species from the ultimobranchial gland.
More description
DC7967 calpeptin Featured
calpeptin is Ca2+-dependent protease,calpain inhibitor
More description
DC20512 VHL ligand 1 Featured
PROTAC-VHL-ligand is a von Hippel–Lindau (VHL) ligand used for the proteolysis targeting chimeras (PROTACs) method, induces target protein degradation..
More description
DC8456 Cardiogenol C (hydrochloride) Featured
Cardiogenol C is a diaminopyrimidine that induces cardiomyogenesis in mouse embryonic stem cells.
More description
DC10903 CAY10465 Featured
CAY10465 is an analog of resveratrol acting as a potent and selective aryl hydrocarbon receptor agonist, with a Ki of 0.2 nM.
More description
DC10449 CB7921220 Featured
CB7921220 is an inhibitor of Adenylyl Cyclase isoform-1 (AC1) and isoform-6 (AC6).
More description

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X